A cerebrospinal fluid microRNA signature as biomarker for glioblastoma

被引：104

作者：

Akers, Johnny C. ^{[1
]}

Hua, Wei ^{[2
]}

Li, Hongying ^{[3
]}

Ramakrishnan, Valya ^{[1
]}

Yang, Zixiao ^{[2
]}

Quan, Kai ^{[2
]}

Zhu, Wei ^{[2
]}

Li, Jie ^{[1
]}

Figueroa, Javier ^{[1
]}

Hirshman, Brian R. ^{[1
]}

Miller, Brittney ^{[1
]}

Piccioni, David ^{[4
]}

Ringel, Florian ^{[5
]}

Komotar, Ricardo ^{[6
]}

Messer, Karen ^{[3
]}

Galasko, Douglas R. ^{[7
]}

Hochberg, Fred ^{[1
]}

Mao, Ying ^{[7
,8
]}

Carter, Bob S. ^{[1
]}

Chen, Clark C. ^{[1
]}

机构：

[1] Univ Calif San Diego, Ctr Theoret & Appl Neurooncol, San Diego, CA 92103 USA

[2] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China

[3] UC San Diego Hlth Syst, Moores Canc Ctr, Biostat Dept, La Jolla, CA USA

[4] UC San Diego Hlth Syst, Moores Canc Ctr, Dept Neurosurg, La Jolla, CA USA

[5] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurosurg, Munich, Germany

[6] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA

[7] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA

[8] Fudan Univ, Inst Brain Sci, Collaborat Innovat Ctr Brain Sci, State Key Lab Med Neurobiol, Shanghai, Peoples R China

来源：

ONCOTARGET | 2017年 / 8卷 / 40期

关键词：

extracellular vesicle; CSF; liquid biopsy; EXOSOMES; BIOPSY; DIAGNOSIS; RESECTION; MIRNAS; LUMBAR; BRAIN; SET;

D O I：

10.18632/oncotarget.18332

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Purpose: To develop a cerebrospinal fluid (CSF) miRNA diagnostic biomarker for glioblastoma. Experimental Design: Glioblastoma tissue and matched CSF from the same patient (obtained prior to tumor manipulation) were profiled by TaqMan OpenArray (R) Human MicroRNA Panel. CSF miRNA profiles from glioblastoma patients and controls were created from three discovery cohorts and confirmed in two validation cohorts. Results: miRNA profiles from clinical CSF correlated with those found in glioblastoma tissues. Comparison of CSF miRNA profiles between glioblastoma patients and non-brain tumor patients yielded a tumor "signature" consisting of nine miRNAs. The " signature" correlated with glioblastoma tumor volume (p=0.008). When prospectively applied to cisternal CSF, the sensitivity and specificity of the 'signature' for glioblastoma detection were 67% and 80%, respectively. For lumbar CSF, the sensitivity and specificity of the signature were 28% and 95%, respectively. Comparable results were obtained from analyses of CSF extracellular vesicles (EVs) and crude CSF. Conclusion: We report a CSF miRNA signature as a "liquid biopsy" diagnostic platform for glioblastoma.

引用

页码：68769 / 68779

页数：11

共 40 条

[1] Comparing the risks of frameless stereotactic biopsy in eloquent and noneloquent regions of the brain: a retrospective review of 284 cases Clinical article
Air, Ellen L.
Leach, James L.
Warnick, Ronald E.
McPherson, Christopher M.
[J]. JOURNAL OF NEUROSURGERY, 2009, 111 (04) : 820 - 824
[2] Optimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluid
Akers, Johnny C.
Ramakrishnan, Valya
Yang, Isaac
Hua, Wei
Mao, Ying
Carter, Bob S.
Chen, Clark C.
[J]. CANCER BIOMARKERS, 2016, 17 (02) : 125 - 132
[3] Comparative Analysis of Technologies for Quantifying Extracellular Vesicles (EVs) in Clinical Cerebrospinal Fluids (CSF)
Akers, Johnny C.
Ramakrishnan, Valya
Nolan, John P.
Duggan, Erika
Fu, Chia-Chun
Hochberg, Fred H.
Chen, Clark C.
Carter, Bob S.
[J]. PLOS ONE, 2016, 11 (02):
[4] miR-21 in the Extracellular Vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker Development
Akers, Johnny C.
Ramakrishnan, Valya
Kim, Ryan
Skog, Johan
Nakano, Ichiro
Pingle, Sandeep
Kalinina, Juliya
Hua, Wei
Kesari, Santosh
Mao, Ying
Breakefield, Xandra O.
Hochberg, Fred H.
Van Meir, Erwin G.
Carter, Bob S.
Chen, Clark C.
[J]. PLOS ONE, 2013, 8 (10):
[5] VALUE OF CEREBROSPINAL-FLUID CYTOLOGY FOR DIAGNOSIS OF MALIGNANCIES IN CENTRAL NERVOUS-SYSTEM
BALHUIZEN, JC
BOTS, GTAM
SCHABERG, A
BOSMAN, FT
[J]. JOURNAL OF NEUROSURGERY, 1978, 48 (05) : 747 - 753
[6] Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma
Baraniskin, Alexander
Kuhnhenn, Jan
Schlegel, Uwe
Maghnouj, Abdelouahid
Zoellner, Hannah
Schmiegel, Wolf
Hahn, Stephan
Schroers, Roland
[J]. NEURO-ONCOLOGY, 2012, 14 (01) : 29 - 33
[7] Key concepts in glioblastoma therapy
Bartek, Jiri, Jr.
Ng, Kimberly
Bartek, Jiri
Fischer, Walter
Carter, Bob
Chen, Clark C.
[J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83 (07) : 753 - 760
[8] Histological yield, complications, and technological considerations in 114 consecutive frameless stereotactic biopsy procedures aided by open intraoperative magnetic resonance imaging
Bernays, RL
Kollias, SS
Khan, N
Brandner, S
Meier, S
Yonekawa, Y
[J]. JOURNAL OF NEUROSURGERY, 2002, 97 (02) : 354 - 362
[9] MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells
Chan, JA
Krichevsky, AM
Kosik, KS
[J]. CANCER RESEARCH, 2005, 65 (14) : 6029 - 6033
[10] Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Chin, L.
Meyerson, M.
Aldape, K.
Bigner, D.
Mikkelsen, T.
VandenBerg, S.
Kahn, A.
Penny, R.
Ferguson, M. L.
Gerhard, D. S.
Getz, G.
Brennan, C.
Taylor, B. S.
Winckler, W.
Park, P.
Ladanyi, M.
Hoadley, K. A.
Verhaak, R. G. W.
Hayes, D. N.
Spellman, Paul T.
Absher, D.
Weir, B. A.
Ding, L.
Wheeler, D.
Lawrence, M. S.
Cibulskis, K.
Mardis, E.
Zhang, Jinghui
Wilson, R. K.
Donehower, L.
Wheeler, D. A.
Purdom, E.
Wallis, J.
Laird, P. W.
Herman, J. G.
Schuebel, K. E.
Weisenberger, D. J.
Baylin, S. B.
Schultz, N.
Yao, Jun
Wiedemeyer, R.
Weinstein, J.
Sander, C.
Gibbs, R. A.
Gray, J.
Kucherlapati, R.
Lander, E. S.
Myers, R. M.
Perou, C. M.
McLendon, Roger
[J]. NATURE, 2008, 455 (7216) : 1061 - 1068

← 1 2 3 4 →